Clinical Science · 2019 · 22 citations · 37 references
Life SciencesBiochemistryPharmacologyApoptosisAutophagyMolecular PharmacologyAutophagy DysfunctionAutophagy In DiseaseAutophagy ModulationAutophagy RegulationHepatic PathophysiologyLiver DiseaseAlcohol-induced HepatotoxicityAutophagy ImpairmentAutophagy In Adipose TissueAutophagy PathwayGut-liver Axis DysfunctionPeroxisome Proliferator-activated Receptor Alpha (Ppar-alpha) SignalingPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated Receptors
Abstract Background: Reversal of alcohol-induced peroxisome proliferator-activated receptor (PPAR) α (PPARα) and PPARδ dysfunction has been reported to decrease the severity of alcoholic steatohepatitis (ASH). Autophagy is essential for cell survival and tissue energy homeostasis. Emerging evidence indicates that alcohol-induced adipose tissue (AT) autophagy dysfunction contributes to injury in the intestine, liver, and AT of ASH. Methods: The effects and mechanisms of dual PPARα/δ agonist elafibranor on autophagy stimulation were investigated using mice with ASH. Results: C57BL/6 mice on ethanol diet showed AT dysfunction, disrupted intestinal barrier, and ASH, which was accompanied by alcohol-mediated decrease in PPARα, PPARδ, and autophagy levels in intestine, liver, and AT. Chronic treatment with elafibranor attenuated AT apoptosis and inflammation by restoration of tissue PPARα, PPARδ, and autophagy levels. In ASH mice, alcohol-induced AT dysfunction along with increased fatty acid (FA) uptake and decreased free FA (FFA) release from AT was inhibited by elafibranor. The improvement of AT autophagy dysfunction by elafibranor alleviated inflammation and apoptosis-mediated intestinal epithelial disruption in ASH mice. Acute elafibranor incubation inhibited ethanol-induced ASH-mice-sera-enhanced autophagy dysfunction, apoptosis, barrier disruption, and intracellular steatosis in Caco-2 cells and primary hepatocytes (PHs). Conclusion: Altogether, these findings demonstrated that the PPARα/δ agonist, elafibranor, decreased the severity of liver injury by restoration of alcohol-suppressed AT autophagy function and by decreasing the release of apoptotic markers, inflammatory cytokines, and FFA, thereby reducing intestinal epithelium disruption and liver inflammation/apoptosis/steatosis in ASH mice. These data suggest that dual PPAR agonists can serve as potential therapeutic agents for the management of ASH.
37
Intestinal Mucosal Lesion in Low-Flow States
Chu-Jeng Chiu · Archives of Surgery · 1970 · 1.8K citations
Life Sciences, Pathology, Physiology +17
Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation
James Harris, Michelle Hartman, Caitrionna Roche et al. · Journal of Biological Chemistry · 2011 · 785 citations · Full text
Ellen Wirawan, Lieselotte Vande Walle, Kristof Kersse et al. · Cell Death and Disease · 2010 · 670 citations · Full text
Bart Staels, A. Rubenstrunk, Benoît Noël et al. · Hepatology · 2013 · 405 citations
Medicine, Pharmacology, Hepatology +15